Category: Donors
Ryma Nasrallah has built her career around philanthropy. A Partner at Borden Ladner Gervais LLP, Ryma specializes in advising registered charities and non-profit organizations, and she’s often helped charitable organizations and foundations get off the ground. She recently took it one step further and made it personal, making her largest ever donation to our Campaign to Create Tomorrow. With an ambitious $500-million fundraising goal, it is the largest campaign in our city’s history.
Now, on top of her roles as the Vice-Chair of the Canadian Bar Association’s Charities and Not-for-Profit Section and serving on the executive of the Ontario Bar Association’s Charities and Not-for-Profit Section, Ryma has joined The Ottawa Hospital Foundation’s Board of Directors.
Learn more about what motivated Ryma to give and get involved — and what you can gain by giving gifts of securities
Q: You recently made your largest gift ever when you gave to the Campaign to Create Tomorrow — what motivated this?
A: After joining the Board of Directors of The Ottawa Hospital Foundation, I was inspired by all the donors who had generously contributed to the Campaign to Create Tomorrow. I wanted to push myself to make my most significant donation in hopes I would inspire others around me to do the same and help reshape the future of healthcare in Ottawa.
Q: What impact do you hope your gift will have and why should others give?
A: I hope my gift will bring The Ottawa Hospital one step closer to delivering a new, state-of-the-art hospital. Building a new hospital is a once-in-a-generation opportunity, and I believe we all have a duty to do what we can to help. Every dollar counts.
Q: Why did you decide to join the Foundation’s Board of Directors?
A: I joined to give back and strengthen my ties to The Ottawa Hospital, because healthcare is so important to me and my family. I am excited to support the largest fundraising campaign in Ottawa’s history and to help The Ottawa Hospital transform and revolutionize healthcare.
Q: Based on your experience with your own clients, what are the benefits of giving gifts of securities?
A: The benefits of gifting publicly listed securities are threefold.
First, gifting publicly listed securities entitles the donor to an official donation receipt equal to the fair market value of the securities on the date they are donated to a registered charity. An official donation receipt will result in a charitable deduction for corporate donors or a non-refundable charitable tax credit for individual donors that will reduce income taxes.
Second, the donor may be exempt from paying any capital gains tax on the appreciated value of the publicly listed securities. In order to receive this favourable tax treatment, the donor must gift the publicly listed securities directly to the registered charity. If the donor sells the securities in the open market and donates the cash proceeds, they will be subject to income tax on any resulting capital gain. By donating the publicly listed securities directly to a registered charity, the donor benefits by paying no capital gains tax on the disposition, and the charity benefits by receiving the full value of the securities.
Third, if the publicly listed securities are held by a corporation — including an individual’s holding company or business — the full amount of the capital gain is added to the corporation’s capital dividend account (CDA). Amounts in the CDA allow the corporation to pay tax-free dividends to its shareholders. Usually, only half of a capital gain is added to the capital dividend account. This extra amount in the CDA can be distributed to the shareholders of the corporation on a tax-free basis, which results in additional tax savings.
Q: What would you tell a donor who is nervous to try giving a gift of securities?
A: There is no reason to be nervous about gifting publicly listed securities. Although it may sound daunting, it is frequently done. Foundation staff are familiar with the process and are ready to help. They will work closely with the donor’s financial advisor to complete the donation. The benefits of gifting publicly listed securities significantly outweigh any additional steps.
Q: With proposed tax changes on the horizon next year, when is the best time for donors to give gifts of securities and what should donors know about these changes?
A: The 2023 Federal Budget introduced new rules for the Alternative Minimum Tax (AMT) regime that will increase the tax cost for high-income individuals donating publicly listed securities to registered charities. The AMT is a parallel tax calculation that allows fewer deductions, exemptions, and tax credits than under the ordinary income tax rules, and that currently applies a flat 15% tax rate with a $40,000 basic exemption. The taxpayer pays the AMT or regular tax, whichever is the highest.
Budget 2023 proposed changes to the AMT calculation include increasing the AMT rate to 20.5% and the basic exemption to $173,000, which raises the amount of income an individual would need to trigger the AMT. Notable changes for high-income individuals donating publicly listed securities include adjusting the inclusion rate for capital gains resulting from the donation of publicly listed securities from 0% to 30% and limiting the charitable donation tax credit by half. These changes will reduce the financial incentive for these individuals to donate publicly listed securities.
The proposed changes will come into force for taxation years that begin after 2023. So, to take full advantage of the current tax benefits, the best time for individual donors to gift publicly listed securities is before December 31, 2023.
Published: September 2023
Before January 2008, Georges Gratton and Jeannine Constantin’s family hadn’t needed The Ottawa Hospital. Living in Boucherville, Quebec and then in the Outaouais region of western Quebec, they had always received care at their local hospitals and clinics. But when their grown daughter, Geneviève Gratton, was diagnosed with acute lymphoblastic leukemia, she needed specialized care and was transferred to The Ottawa Hospital within one day of her diagnosis.
Specialized care for patients from western Quebec and beyond
This scenario is not unique to Geneviève’s case. In fact, The Ottawa Hospital regularly provides care that extends well beyond the city’s borders, and one quarter of our patients live in a rural area.
Many patients from the Outaouais region choose to or need to come to The Ottawa Hospital, particularly the Emergency Department for care, or like in Geneviève’s case, for specialized cancer care that they are unable to access closer to home. In addition to those who travel from western Quebec, patients also come from across eastern Ontario and as far away as Nunavut. At times, people from coast to coast come to our hospital for care they can’t get anywhere else.
“Our hospital is uniquely positioned to provide care for patients coming to us from far and wide and with a wide range of needs.”
— Suzanne Madore
According to Suzanne Madore, Chief Operating Officer and Chief Nursing Executive, The Ottawa Hospital plays an important role in healthcare delivery in Ottawa and beyond. “Our hospital is uniquely positioned to provide care for patients coming to us from far and wide and with a wide range of needs,” she says. “We have also worked hard to develop multiple collaborative partnerships within the region that provide our patients with access to specialized services.”
Diagnosis leads to stem cell transplant
While this was the first time Geneviève needed our hospital, she was grateful to be receiving the specialized cancer care she needed. At the time, she was working as a notary in Quebec and was a busy mom of three young children — aged 9, 6, and 1 — when her spleen suddenly ruptured.
A month later, she and her husband, Jean-François, noticed she wasn’t healing properly from the surgery to her spleen. She was incredibly weak and pale and was also experiencing a host of other symptoms including red spots all over her body (petechiae), constant nightmares, and fevers.
“My husband brought me to the Hull hospital on two occasions, and when they were taking my blood during one of those visits, my blood started gushing out like a fountain,” recalls Geneviève. “A hematologist took a biopsy and found out it was leukemia.”
Within 24 hours, Geneviève was transferred to The Ottawa Hospital where her specialized care began right away.
Family rallies following leukemia diagnosis
Geneviève’s entire network of family and friends immediately came together to support not only her, but also her husband and her children throughout this ordeal.
“It was like a net unfolding to protect and support me.”
— Geneviève Gratton
After her initial treatment, her medical team said that she needed an allogeneic stem cell transplant, meaning the stem cells needed to come from a donor, rather using Geneviève’s own stem cells. Fortunately, one of Geneviève’s two siblings, her sister Julie Gratton, was a perfect match, and she didn’t hesitate to donate her own stem cells to help save her little sister.
“Although I feared the whole thing, I would do the same if Geneviève would need it again. I was reassured by The Ottawa Hospital on the process of what I would have to do to give my stem cells. It wasn’t painful, and I was well treated” says Julie.
“I would do the same if Geneviève would need it again.”
— Julie Gratton
For Geneviève’s parents, it was a frightening time with a rollercoaster of emotions. They were worried for her and the seriousness of her diagnosis and also deeply grateful that Julie was a match and willing to donate her stem cells. As the transplant date approached, the entire family anxiously waited and hoped for the best.
Stem cell excellence at The Ottawa Hospital
Thankfully, Geneviève was in the most capable hands. In fact, The Ottawa Hospital is a major centre for the growing area of stem cell transplantation and research and is home to the Transplantation and Cellular Therapy Program, the Sprott Centre for Stem Cell Research and the Sinclair Centre for Regenerative Medicine..
This expertise paid off. Geneviève’s initial care team included Dr. Mitchell Sabloff, Director of the Ottawa Hospital Leukemia Program, and Hematologist Dr. Jill Fulcher. Following her stem cell transplant on March 29th, 2018, she was cared for by Dr. Natasha Kekre, who was recently named the Research Chair in Advanced Stem Cell Therapy. Dr. Kekre and extended care teams at the General Campus supported Geneviève each step of the way.
The stem cell transplant was a success, and Geneviève has been in remission ever since.
In the weeks following the transplant, Geneviève was weak and fragile, so she stayed in with her parents, who had moved into an apartment in the Ottawa area to care for her. Being at home with her husband and children would have been dangerous for Geneviève, since her immune system was still recovering after the stem cell transplant.
Being apart was difficult, but she was fortunate to be in loving care of parents. With their help, she regained the strength she needed for this next step to healing.
“We wanted to show how thankful we were for what they had done, their kindness and sensitivity in all the care they provided me … My heart was filled with gratitude.”
— Geneviève Gratton
“On the 100th day after my stem cell transplant, since I had passed the darkest period of my life, my mother and I brought two huge cakes to The Ottawa Hospital — one for the team on Module L and one for the fifth-floor team,” says Geneviève. “We wanted to show how thankful we were for what they had done, their kindness and sensitivity in all the care they provided me since January 2018. My heart was filled with gratitude.”
“We are infinitely grateful”
“We want to support the research and care efforts of the hospital and believe that even a small regular donation expresses our support of the hospital.”
— Georges Gratton
It was the lifesaving care Geneviève received at The Ottawa Hospital that inspired Georges and Jeannine to donate, and they’ve been giving ever since – each month. They want to ensure the hospital has the funds they need to continue providing expert care to patients like their daughter.
“We want to support the research and care efforts of the hospital and believe that even a small regular donation expresses our support of the hospital,” says Georges.
Their monthly donations are also a meaningful way to express their deep gratitude for seeing Geneviève beat her cancer and get back to watching her three children grow up.
“We give to say thank you for the wonderful care Geneviève received,” says Jeannine. “The Ottawa Hospital saved her life, and we are infinitely grateful.”
Geneviève is now back to work and spending time with her kids, doing the things she loves most, like reading, boating, and walks in Gatineau Park. She’s not only grateful for her health, but also making the best of each day she’s been given.
Published: July 2023
Next year, Jean Teron will proudly wear the 100-year-old nursing pin given to her mother in 1924 when she graduated — the same year the Civic Hospital opened its doors on Carling Avenue. “The Ottawa Hospital has been a lifelong part of my family,” says Jean. “My mother and sister were nurses trained there. My siblings and I and my children were born there.”
It’s that personal connection to the hospital — and to her city — that helped inspire Jean’s $100,000 gift to The Campaign to Create Tomorrow.
“The Ottawa Hospital has been a lifelong part of my family.”
— Jean Teron
But this is not the first time the Teron family has made an indelible mark on our city. Jean’s late husband, Bill Teron, was known as the “father of Kanata” for creating a small town amidst farmer’s fields and rock outcroppings west of Ottawa. What started as a dream in the 1960s became a vibrant, thriving place to call home. The Terons know better than most the importance of community.
Jean, Bill, and their family have long been supporters of The Ottawa Hospital — changing lives for decades. In 1977, Bill and Jean donated a kidney preserving machine that allowed surgeons to store and preserve kidneys for up to 40 hours while they matched kidneys with patients on a waitlist. In the years since, they helped build the Dr. Chris Carruthers Operating Room with Jean leading the way as Chair of the $1-million campaign. She was also part of The Ottawa Hospital Foundation’s Gala committee for years, helping raise funds for research. Together, the Terons contributed to the Legacy Campaign, the Centre for Stem Cell and Gene Therapy, and to fundraising efforts for the hospital through Tamarack Ottawa Race Weekend.
Jean’s daughter, Kim Teron, has also been actively involved with Partners Investing in Parkinson’s Research (PIPR) since 2011, when Kim’s husband Ross was diagnosed with Parkinson’s disease. Jean and other family members have rallied behind Kim who has worked tirelessly to raise funds and awareness for this cause.
It’s clear the Teron family is determined to make a difference.
Now, Jean’s generous gift will play a vital role in propelling The Campaign to Create Tomorrow forward, helping forge a brighter future for the community she loves by advancing medical research, expanding state-of-the-art facilities, and transforming patient care.
“As one citizen, it’s important to me that individuals and businesses in Ottawa give to this campaign to show how much the community supports the building of a great new hospital.”
— Jean Teron
Jean hopes her gift will help ignite a spark, inspiring others to follow her lead. “As one citizen, it’s important to me that individuals and businesses in Ottawa give to this campaign to show how much the community supports the building of a great new hospital,” she says. “I do hope that when people see lists of those who have donated, they too will be encouraged to participate.”
Published: June 2023
When non-Hodgkins Lymphoma returned shortly after completing six rounds of chemotherapy, 73-year-old Patrick Morris was shocked to his core.
“No one plans to get cancer. No one prepares for cancer. Receiving this diagnosis was profoundly shocking. It jolted me. It was a life-changing event,” remembers Patrick. “You realize very suddenly that the life you had before will never be the same. A cancer diagnosis humbles you.”
Patrick’s hematologist, Dr. Andrew Aw, called it “refractory cancer”, because while it had responded to chemotherapy, it started to grow again — quickly. So, Dr. Aw scheduled a new round of chemotherapy to begin immediately.
This was a challenging time for Patrick, who, up until this point in his life, was fortunate to be in good health and never one to sit idly. In fact, he enjoyed significant success as an elite ski jumper in the late 60s and early 70s, and that same drive propelled him to the top of his industry as an award-winning, Ottawa-area real estate agent with a successful brokerage, the Morris Home Team at Royal LePage Performance Realty.
Caring for his ‘soulmate’
An important part of Patrick’s success story was his wife, Susan. Vibrant, caring, and fun-loving, Susan was his business partner for years and his soulmate. She was also an outstanding mom to their three daughters and a doting “nana”. But in 2017, Susan developed Alzheimer’s and Lewy Body Dementia. Patrick cared for her 24/7, but she continued to decline and eventually required long-term care in 2021.
“The memories we shared are now my treasured souvenirs.”
– Patrick Morris
“I was lucky to have Susan as my wife, my business partner for many years, and my soulmate,” says Patrick. “Our marriage worked because it was a never-ending love story.”
While she no longer recognizes Patrick or their daughters, he remains deeply grateful for more than four decades together. “The memories we shared are now my treasured souvenirs.”
Exploring CAR T-cell therapy
As Patrick faced his own health challenges, it would seem the cancer was not backing down. During his second series of treatments, he received yet another shock – the cancer had spread to his lower neck. Dr. Aw was concerned, but he had a plan — one that would ultimately save Patrick’s life.
“Dr. Aw told me ‘We cannot let this get to your brain.’ And that’s when we stopped the second chemo treatment, and he recommended daily radiation.” Then, Dr. Aw explored whether Patrick was eligible for CAR T-cell therapy.
This revolutionary therapy uses the patient’s own immune cells, known as T-cells, to treat their cancer. T-cells play a critical role in the immune system by killing abnormal cells, but sometimes, cancerous cells can hide from the T-cells that are meant to kill them. However, with CAR-T therapy, those T-cells are collected and reprogrammed in the lab to be able to recognize the cancerous cells. These reprogrammed cells are then infused back into the patient, where they multiply by the millions to attack and kill the cancer.
“Every doctor, nurse, physiotherapist — everyone associated with my CAR T-cell therapy — was determined to see me have a future.”
– Patrick Morris
Patrick’s T-cells were sent to the United States for reprogramming, but researchers at The Ottawa Hospital, working with colleagues in BC, have developed the first made-in-Canada CAR-T therapy. This approach is enabling more equitable access to CAR-T therapy across the country, while also fueling groundbreaking research into better CAR-T therapies that may work for more kinds of cancer. This kind of research is possible because of the hospital’s world-class research facilities and resources, including the Biotherapeutics Manufacturing Centre and Ottawa Methods Centre.
Cancer treatment delivers knockout punch
For Patrick, CAR T-cell therapy proved to be a knockout punch for the lymphoma. Since receiving the treatment in November 2022, Patrick’s scans show no signs of cancer.
“The CAR T-cell therapy saved my life. I am in remission and have a future.”
– Patrick Morris
“When you’re faced with your own mortality, it impacts your life forever. You want the finest medical science and practitioners on your side,” says Patrick. “As an inpatient, I witnessed firsthand the dedication, commitment, and devotion of every healthcare worker. Every doctor, nurse, physiotherapist — everyone associated with my CAR T-cell treatment — was determined to see me have a future.”
The support he received from his care team was mirrored by his family and community, who, as Patrick is quick to point out, are also affected when a loved one is diagnosed with cancer. “My daughters in Ottawa were my angels on the ground. They put hundreds of kilometres on their cars, driving me back and forth to the Cancer Centre and ensuring I was cared for at home,” recalls Patrick. “My youngest daughter who lives out of town was in constant communication with me, and if she lived here, she would have shared the responsibility of support. My siblings and relatives were huge cheerleaders. My neighbours, friends, and business colleagues were rooting for me every day. There were so many helpful and supportive people. It helped me remain positive especially during the most difficult hours.”
Deep gratitude leads to first-time donation
Never far from Patrick’s mind while battling lymphoma was Susan and what she would say to him if she were able. “I know that I must look to the future. That is something my wife would say to me, and she would insist that I listen to her,” says Patrick. “It makes me smile because when I listened to Susan, she was usually correct.”
With the future in mind, and to show his gratitude, Patrick decided to make a sizable first-time donation to The Ottawa Hospital of $150,000. He hopes it will inspire others to give and will help future patients benefit from the groundbreaking treatments being developed at the hospital — like the CAR-T-cell therapy he received. He is also giving his time volunteering as a table host for the hospital’s annual President’s Breakfast and rallying others to join him for the important event.
“I will be a proud donor to The Ottawa Hospital to help support the development of more research.”
– Patrick Morris
“The Ottawa Hospital is a forerunner in immunotherapy,” he says. “I will be a proud donor to help support the development of more research — because more research produces more discoveries. CAR T-cell therapy saved my life. I am in remission and have a future.”
June 19, 2023, OTTAWA, ON – Partners with Deloitte Canada stepped forward to support the historic Campaign to Create Tomorrow in an unprecedented way. With a goal of $1 million, members of the Deloitte partner team showed their dedication and commitment to this once-in-a-generation opportunity.
Through the leadership of Mark Noonan, Vice Chair, Deloitte, and member of The Ottawa Hospital Foundation Board of Directors, the partners realized their goal. “Corporate responsibility is vitally important to further enhance our city, especially when it comes to our health. Our partners at Deloitte, along with their family members and friends, understood the need for this new hospital campus and we now encourage our peers in the industry to join us to help build the most patient-centred and technologically advanced research hospital in the country. We couldn’t be prouder to lead the way.”
With 50 partners from Deloitte’s Ottawa group participating in this special effort to support the Campaign to Create Tomorrow, Tim Kluke, President and CEO of The Ottawa Hospital Foundation said this is an excellent example of businesses coming together to reshape healthcare for future generations. “We’re deeply grateful to Mark, who led this fundraising initiative and engaged his partners. They put their hands up and each made a personal commitment to the campaign. They recognized the need to build the new hospital campus and take our research to the next level. It’s really inspiring, and I believe other community-minded businesses will follow suit.”
To join the Campaign to Create Tomorrow in support of The Ottawa Hospital, visit CreatingTomorrow.ca.
About The Ottawa Hospital:
The Ottawa Hospital is one of Canada’s top learning and research hospitals where we are guided by our vision to provide the world-class and compassionate care we would all want for our loved ones. Our multi-campus hospital, affiliated with the University of Ottawa, is home to the Regional Trauma Centre and Cancer Centre, and to new discoveries that are adopted globally to save lives.
Backed by generous support from the community, we are focused on reshaping the future of healthcare to improve the lives of our diverse population of patients from eastern Ontario, western Quebec, and Nunavut.
For more information about The Ottawa Hospital, visit OHFoundation.ca.
-30-